Sequence Similarity Clusters for the Entities in PDB 1G9N

Entity #1 | Chains: G
ENVELOPE GLYCOPROTEIN GP120 protein, length: 313 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 7 10 3482
95 % 8 11 3642 Flexibility: Low
Max RMSD: 1.9, Avg RMSD: 1.0
PDBFlex
90 % 9 13 3020
70 % 93 200 130
50 % 93 200 152
40 % 93 200 165
30 % 93 203 182
Entity #2 | Chains: C
T-CELL SURFACE GLYCOPROTEIN CD4 protein, length: 185 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 23 40 869
95 % 25 46 820 Flexibility: Low
Max RMSD: 2.4, Avg RMSD: 1.2
PDBFlex
90 % 25 46 851
70 % 25 46 900
50 % 25 46 944
40 % 25 46 975
30 % 25 46 958
Entity #3 | Chains: L
ANTIBODY 17B, LIGHT CHAIN protein, length: 214 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 3 18252
95 % 22 34 1134 Flexibility: Low
Max RMSD: 5.3, Avg RMSD: 1.2
PDBFlex
90 % 587 857 2
70 % 1865 2747 1
50 % 3793 5577 1
40 % 4307 6322 1
30 % 5349 7862 1
Entity #4 | Chains: H
ANTIBODY 17B, HEAVY CHAIN protein, length: 229 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 19 26 1233
95 % 19 26 1472 Flexibility: Low
Max RMSD: 3.9, Avg RMSD: 1.0
PDBFlex
90 % 19 26 1498
70 % 1834 2706 2
50 % 3794 5577 1
40 % 4308 6322 1
30 % 5350 7862 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 6CNW 1 A humanized antibody SD84h 37965
2 5IVN 1 A BC2-nanobody 30538
3 5E7B 1 A nanobody nano-L06 9838
4 2P45 2 B ANTIBODY CAB-RN05 9838
5 2X1Q 1 A, B GELSOLIN NANOBODY 9844
6 5U64 1 B VHH-28 9838
7 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
8 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
9 4B41 1 A, B ANTIBODY G7 9844
10 4NZU 1 L 13PL heavy chain Fab 9606
11 4NZU 2 H 13PL light chain Fab 9606
12 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
13 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
14 5IMM 1 B Nanobody 9835
15 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
16 5NLU 1 A single domain llama antibody Nb36 9844
17 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
18 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
19 1MEX 1 L Fab 29G12 light chain 10090
20 1MEX 2 H Fab 29G12 heavy chain 10090
21 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
22 5IMK 1 B Nanobody 9835
23 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
24 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
25 6CWK 1 A Anti-Ricin antibody 30538
26 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
27 4BUH 1 A, B CLONE M0418 SCFV 9606
28 4B50 1 A 2H10 LLAMA VHH 9844
29 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
30 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
31 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
32 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
33 6DBA 1 A, B nanobody VHH R303 9838
34 5YD4 1 A, C, E, G scFv 4B08 10090
35 5YD3 1 A, C, E, G scFv 4B08 10090
36 2XT1 2 B CAMELID VHH 9 30538
37 5UD9 1 H Fab heavy chain 9606
38 5UD9 2 L Light chain 9606
39 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
40 4P48 1 A Antibody scFv 180 9031
41 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
42 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
43 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
44 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
45 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
46 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
47 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
48 5J1S 3 C VHH domain BS-2 30538
49 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
50 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
51 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
52 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
53 6MEE 2 B, D antibody HEPC74 Light Chain 9606
54 6BJZ 1 H 5c8 Fab Heavy chain 9606
55 6BJZ 2 L 5c8 Fab Light chain 9606
56 5J1T 3 C VHH domain BS-2 30538
57 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
58 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
59 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
60 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
61 4XCF 1 L 4E10 Fab light chain 9606
62 4XCF 2 H 4E10 Fab heavy chain 9606
63 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
64 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
65 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
66 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
67 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
68 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
69 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
70 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
71 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
72 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
73 5X08 1 H Fab 4E10 Heavy chain 9606
74 5X08 2 L Fab 4E10 Light chain 9606
75 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
76 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
77 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
78 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
79 6MEG 1 H antibody HEPC46 Heavy Chain 9606
80 6MEG 2 L antibody HEPC46 Light Chain 9606
81 2X1O 1 A, B GELSOLIN NANOBODY 9844
82 4QGY 1 A, B nanobody n25, VH domain 9844
83 5C2B 1 H scFv 3B4 heavy chain 9606
84 4XAW 1 L 4E10 Fab light chain 9606
85 4XAW 2 H 4E10 Fab heavy chain 9606
86 5VNV 1 A Nb.b201 32630
87 4P49 1 A Antibody scFv B8 9031
88 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
89 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
90 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
91 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
92 5DXW 1 A PD-L1 nanobody 9835
93 5UCB 1 H Fab Heavy Chain 9606
94 5UCB 2 L Fab Light Chain 9606
95 2VXV 1 H HUMAN IGG ABT-325 9606
96 2VXV 2 L HUMAN IGG ABT-325 9606
97 4N9O 2 B Nanobody Nb484 Nb484 9844
98 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
99 4GXV 1 H, I Antibody 1F1, heavy chain 9606
100 4GXV 2 L, M Antibody 1F1, light chain 9606
101 2VXT 1 H MURINE IGG 125-2H 10090
102 2VXT 3 L MURINE IGG 125-2H 10090
103 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
104 1T2J 1 A M12-Variable Heavy domain 9606
105 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
106 6DBF 2 B InlB specific VHH R303 9838
107 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
108 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
109 6DBG 2 C, D VHH R303 9838
110 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
111 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
112 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
113 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
114 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
115 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
116 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
117 5W24 1 L 5C4 Fab Light Chain 10090
118 5W24 2 H 5C4 Fab Heavy Chain 10090
119 4HPY 1 H CH59 Fab heavy chain 9606
120 4HPY 2 L CH59 Fab light chain 9606
121 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
122 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
123 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
124 5VM6 1 A single domain camelid nanobody VHH T10 9844
125 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
126 4JG1 1 L Fab light chain 9606
127 4JG1 2 H Fab heavy chain 9606
128 6E65 1 L TB31F Fab light chain 9606
129 6E65 2 H TB31F Fab heavy chain 9606
130 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
131 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
132 4KML 2 B Nanobody 9844
133 5VF2 1 A scFv 2D10 10090
134 5I8C 1 A VRC34.01 Fab heavy chain 9606
135 5I8C 2 B VRC34.01 Fab light chain 9606
136 4O5L 1 L Fab F045-092 light chain 9606
137 4O5L 2 H Fab F045-092 heavy chain 9606
138 5MYX 1 A, C Fab c#24 light chain 10090
139 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
140 4Z9K 2 B VHH2(F5) antibody 30538
141 3IFL 1 L 12A11 FAB antibody light chain 10090
142 3IFL 2 H 12A11 FAB antibody heavy chain 10090
143 5WK2 1 L M116 LIGHT CHAIN 9606
144 5WK2 2 H M116 HEAVY CHAIN FD 9606
145 3PP4 1 H GA101 Fab heavy chain 10090
146 3PP4 2 L GA101 Fab light chain 10090
147 3KDM 1 A, L Immunoglobulin light chain 9606
148 3KDM 2 B, H Immunoglobulin heavy chain 9606
149 5NIV 1 A Light chain of 5D3 Fab 10090
150 5NIV 2 B Heavy chain of 5D3 Fab 10090
151 5N4J 1 L LIGHT CHAIN 9606
152 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
153 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
154 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
155 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
156 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
157 5X4G 1 A 6H8 Fab heavy chain 10090
158 5X4G 2 B 6H8 Fab light chain 10090
159 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
160 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
161 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
162 4PTU 1 A Antibody pn132p2C05, light chain 9606
163 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
164 4TPR 1 L If kappa light chain 10090
165 4TPR 2 H Fab heavy chain 10090
166 5LMW 1 A Nanobody 9844
167 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
168 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
169 3IFN 1 H 12A11 FAB antibody heavy chain 10090
170 3IFN 2 L 12A11 FAB antibody light chain 10090
171 5U3P 1 H DH511.4 Fab Heavy Chain 9606
172 5U3P 2 L DH511.4 Fab Light Chain 9606
173 6BLA 1 H AMM01 Fab Heavy chain 9606
174 6BLA 2 L AMM01 Fab Light chain 9606
175 5NM0 1 A, B, C, D Nb36 9844
176 4TOY 1 H 35O22 Fab Heavy chain 9606
177 4TOY 2 L 35O22 Fab Light chain 9606
178 6H6Y 2 E, F, G, H Nanobody (VHH) Nano-7 30538
179 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
180 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
181 3NPS 2 B S4 FAB HEAVY CHAIN 9606
182 3NPS 3 C S4 FAB LIGHT CHAIN 9606
183 5I4F 1 A scFv 2D10 10090
184 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
185 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
186 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
187 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
188 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
189 5WN9 1 H scFv 2D10 9606
190 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
191 4XC3 1 L 4E10 Fab light chain 9606
192 4XC3 2 H 4E10 Fab heavy chain 9606
193 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
194 4PPT 1 A Engineered single domain VHH antibody 9844
195 3R0M 1 A, B Llama VHH A12 9844
196 4M5Y 1 H, I Fab 5J8 heavy chain 9606
197 4M5Y 2 L, M Fab 5J8 light chain 9606
198 4TQE 1 L If kappa light chain 10090
199 4TQE 2 H Fab heavy chain 10090
200 3ZKQ 2 D XA4813 9844
201 5YY4 1 A scFv 4B08 10090
202 4I13 2 B Protein ca1697 (nanobody) 9844
203 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
204 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
205 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
206 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
207 5C2U 1 B Nanobody Nanobody 9838
208 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
209 5VSI 2 L CH1/Ckappa Fab light chain 9606
210 1XFP 1 A heavy chain antibody VHH domain 9838
211 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
212 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
213 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
214 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
215 5JXA 1 H VRC03 Heavy chain 9606
216 5JXA 2 L VRC03 Light chain 9606
217 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
218 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
219 4POY 1 A VHH-metal 9844
220 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
221 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
222 5NLW 1 A nanobody Nb36 9844
223 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
224 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
225 3NTC 1 L Fab light chain 10090
226 3NTC 2 H Fab heavy chain 10090
227 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
228 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
229 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
230 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
231 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
232 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
233 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
234 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
235 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
236 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
237 6BE3 1 H Fab (F598) Heavy Chain 9606
238 6BE3 2 L Fab (F598) Light Chain 9606
239 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
240 3G9A 2 B Minimizer 9838
241 4NWU 1 H APE1551 Ab Fab heavy chain 9606
242 4NWU 2 L APE1551 Ab Fab light chain 9606
243 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
244 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
245 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
246 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
247 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
248 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
249 5EWI 1 H VRC38.01 Heavy Chain 9606
250 5EWI 2 L VRC38.01 Light Chain 9606
251 5E2W 1 L AT8 LIGHT CHAIN 10090
252 5E2W 2 H AT8 HEAVY CHAIN 10090
253 5MYK 1 A Fab c#17 light chain 10090
254 5MYK 2 B Fab c#17 heavy chain 10090
255 4NZR 1 H PGT135 heavy chain Fab 9606
256 4NZR 2 L PGT135 light chain Fab 9606
257 5MYO 1 A, C Fab c#6 light chain 10090
258 5MYO 2 B, D Fab c#6 heavy chain 10090
259 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
260 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
261 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
262 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
263 5UEL 1 H 354NC102 Fab Heavy Chain 9606
264 5UEL 2 L 354NC102 Fab Light Chain 9606
265 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
266 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
267 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
268 2P43 2 B ANTIBODY CAB-RN05 9838
269 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
270 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
271 5E2V 1 L AT8 LIGHT CHAIN 10090
272 5E2V 2 H AT8 HEAVY CHAIN 10090
273 4KRN 1 A Nanobody/VHH domain EgA1 9844
274 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
275 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
276 4GFT 2 B Nanobody 9844
277 4TVS 2 a, b VHH Domain BS-1 30538
278 4W6Y 2 B Nanobody NbFedF9 9844
279 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
280 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
281 6EZW 1 B VHH antibody BCD090-M2 9844
282 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
283 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
284 5JUE 1 L light chain of UIC2 Fab 10090
285 5JUE 2 H heavy chain of UIC2 Fab 10090
286 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
287 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
288 1UAC 2 H Ig VH,anti-lysozyme 10090
289 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
290 5JR1 1 H 10E8 heavy chain 9606
291 5JR1 2 L 10E8 mature light chain 9606
292 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
293 6CA7 1 L PCT64_13C light chain 9606
294 6CA7 2 H PCT64_13C heavy chain 9606
295 5VF6 1 A single chain variable fragment 9031
296 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
297 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
298 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
299 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
300 5OB5 2 H fAb Heavy chain 9606
301 5OB5 3 L fAb Light chain 9606
302 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
303 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
304 5I66 1 A 8B6 antibody, heavy chain 10090
305 5I66 2 B 8B6 antibody, light chain 10090
306 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
307 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
308 6BZY 1 H 22D11 Heavy Chain 10090
309 6BZY 2 L 22D11 Light Chain 10090
310 3QQ9 1 C, L 101F LIGHT CHAIN 10090
311 3QQ9 2 D, H 101F HEAVY CHAIN 10090
312 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
313 5TKK 3 L mouse antibody vFP5.01 light chain 10090
314 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
315 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
316 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
317 5W6C 1 H UCA Fab heavy chain 9606
318 5W6C 2 L UCA Fab light chain 9606
319 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
320 5I1K 1 L FAB LIGHT CHAIN 9606
321 5I1K 2 H FAB HEAVY CHAIN 9606
322 3OZ9 1 L Fab NC-1 kappa light chain 10090
323 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
324 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
325 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
326 5V7U 1 L CBTAU-22.1 Fab light chain 9606
327 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
328 5UEA 1 A, H Fab Heavy Chain 9606
329 5UEA 3 B, L Fab Light Chain 9606
330 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
331 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
332 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
333 3G5Y 1 A 175 light chain 10090
334 3G5Y 2 B 175 heavy chain 10090
335 5O02 2 C Nanobody (VHH) Nano-4 30538
336 5NMV 1 L Fab light chain 10088
337 5NMV 2 H Fab heavy chain 10088
338 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
339 4N8C 2 L, M Light chain of monoclonal antibody 10090
340 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
341 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
342 4HGW 1 A Antibody Fab fragment, light chain 10090
343 4HGW 2 B Antibody Fab fragment, heavy chain 10090
344 1NLB 1 L antibody 19D9D6 light chain 10090
345 1NLB 2 H antibody 19D9D6 heavy chain 10090
346 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
347 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
348 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
349 3VFG 1 L 3F8 Light Chain 10090
350 3VFG 2 H 3F8 Heavy Chain 10090
351 4X7F 2 C, D Nano-25 Nanobody 30538
352 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
353 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
354 3QRG 1 L Fab light chain 9606
355 3QRG 2 H Fab heavy chain Fd fragment 9606
356 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
357 5M6A 1 A, B, C, D Bence-Jones light chain 9606
358 4LLY 2 B, D light chain Clambda 9606
359 4LGR 2 B Camelid nanobody (VHH3) 30538
360 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
361 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
362 5EZI 1 H Fab c12 heavy chain 9606
363 5EZI 2 L Fab c12 Light chain 9606
364 4K23 1 H anti-uPAR antibody, heavy chain 10090
365 4K23 2 L anti-uPAR antibody, light chain 10090
366 5J57 2 B VHH single chain antibody V5E1 30538
367 3NCJ 1 L Fab15 Mut8 light chain 9606
368 3NCJ 2 H Fab15 Mut8 heavy chain 9606
369 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
370 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
371 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
372 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
373 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
374 5W05 1 L M59 FAB LIGHT CHAIN 10090
375 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
376 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
377 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
378 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
379 5OMM 2 C Nanobody (VHH) Nano-14 30538
380 5E03 1 A CTLA-4 nanobody 9835
381 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
382 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
383 4M61 1 A, C Fab A52 light chain 10090
384 4M61 2 B, D Fab A52 heavy chain 10090
385 5YE3 1 B 2A7D9 VH CH1 chain 10090
386 5YE3 2 A 2A7D9 L chain 10090
387 5LZ0 1 A, B PorM nanobody 9844
388 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
389 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
390 1UM5 1 L Antibody 21H3 L chain 10090
391 1UM5 2 H Antibody 21H3 H chain 10090
392 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
393 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
394 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
395 4NWT 1 L APE1531 Ab Fab light chain 9606
396 4NWT 2 H APE1531 Ab Fab heavy chain 9606
397 6DBE 1 A, B nanobody VHH R303 9844
398 3WHX 1 A mAb Fab H fragment 10090
399 3WHX 2 B mAb Fab L fragment 10090
400 3NA9 1 L Fab15 light chain 9606
401 3NA9 2 H Fab15 heavy chain 9606
402 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
403 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
404 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
405 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
406 4LRI 1 A, B MSL-109 Light Chain 9606
407 4LRI 2 C, P MSL-109 Heavy Chain 9606
408 2XXC 1 B CAMELID VHH 9 30538
409 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
410 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
411 4JN2 1 A, L anti dabigatran Fab 10090
412 4JN2 2 B, H anti dabigatran Fab 10090
413 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
414 4XBE 2 H 4E10 Fab heavy chain 9606
415 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
416 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
417 6BE2 1 H Fab (F598) Heavy Chain 9606
418 6BE2 2 L Fab (F598) Light Chain 9606
419 3QYC 1 A, B VH domain of IgG molecule 9606
420 4JFZ 1 L Fab light chain 9606
421 4JFZ 2 H Fab heavy chain 9606
422 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
423 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
424 5VAK 2 B Nb914 Nanobody 9844
425 3WIF 1 A mAb Fab H fragment 10090
426 3WIF 2 B mAb Fab L fragment 10090
427 5U6A 1 A Light Chain 9606
428 5U6A 2 B Heavy Chain 9606
429 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
430 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
431 3MBX 1 L X836 LIGHT CHAIN 10090
432 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
433 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
434 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
435 2XXM 2 B CAMELID VHH 9 30538
436 6APC 1 H Epididymis luminal protein 214 9606
437 6APC 2 L IGL@ protein 9606
438 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
439 4HHA 1 A Fab KE5 Fab fragment KE5 9606
440 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
441 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
442 4RGO 2 H 14G8 heavy chain Fab 10090
443 4RGO 3 L 14G8 light chain Fab 10090
444 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
445 5GRY 1 A, G diabody 9606
446 5UEK 2 H Fab 12E Heavy Chain 9606
447 5UEK 3 L Fab 12E Light Chain 9606
448 3NAA 1 L Fab15 Mut5 light chain 9606
449 3NAA 2 H Fab15 Mut5 heavy chain 9606
450 6DBD 1 A, B, C, D nanobody VHH R326 9844
451 1Q0X 1 L Fab 9B1, light chain 10090
452 1Q0X 2 H Fab 9B1, heavy chain 10090
453 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
454 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
455 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
456 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
457 5JDS 1 B Nanobody 9835
458 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
459 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
460 5IK3 2 B, D 1E03 Fab fragment light chain 9606
461 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
462 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
463 5XLI 1 a, b FabL 10090
464 5XLI 2 c, d FabH 10090
465 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
466 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
467 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
468 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
469 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
470 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
471 4WUK 1 H CH65 heavy chain 9606
472 4WUK 2 L CH65 light chain 9606
473 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
474 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
475 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
476 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
477 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
478 5JOP 1 D, L Fab 14.22 light chain 10090
479 5JOP 2 E, H Fab14.22 heavy chain 10090
480 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
481 4HPO 1 H CH58 Fab heavy chain 9606
482 4HPO 2 L CH58 Fab light chain 9606
483 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
484 5UKN 2 L DH522UCA Fab fragment light chain 9544
485 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
486 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
487 5L21 2 B VHH-C2 30538
488 5IT2 1 H heavy chain 9606
489 5IT2 2 L light chain 9606
490 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
491 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
492 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
493 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
494 5FWO 1 A NANOBODY 9844
495 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
496 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
497 5MO3 3 L Fab of monoclonal antibody, light chain 10090
498 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
499 5GZ0 1 A, C FM329 light chain 1383439
500 5GZ0 2 B, D FM329 heavy chain 1383439
501 6DW2 1 A 6078 Fab light chain 9606
502 6DW2 2 B 6078 Fab heavy chain 9606
503 3B9V 1 A, B, C, D heavy chain variable domain 9606
504 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
505 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
506 6BQB 1 L MGG4 Fab light chain 9606
507 6BQB 2 H MGG4 Fab heavy chain 9606
508 4PUB 1 H DX-2930 HEAVY CHAIN 9606
509 4PUB 2 L DX-2930 LIGHT CHAIN 9606
510 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
511 6B14 2 L Light chain of Fab BL3-6S97N 10090
512 5N88 1 A, H VH59 antibody 9606
513 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
514 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
515 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
516 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
517 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
518 5GS3 1 A, H diabody protein 9606
519 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
520 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
521 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
522 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
523 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
524 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
525 5VKD 2 H Fab Heavy Chain 9606
526 5VKD 3 L Fab light chain 9606
527 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
528 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
529 5XHG 1 A, C polypeptide(L) 10090
530 5XHG 2 B, D polypeptide(H) 10090
531 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
532 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
533 3UYR 1 H antibody Fab heavy chain 10090
534 3UYR 2 L antibody Fab light chain 10090
535 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
536 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
537 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
538 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
539 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
540 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
541 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
542 3OAZ 2 K, L Fab 2G12, light chain 9606
543 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
544 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
545 1ZAN 1 L Fab AD11 Light Chain 10116
546 1ZAN 2 H Fab AD11 Heavy Chain 10116
547 6CJK 1 A, C Immunoglobulin Fab light chain 9986
548 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
549 4N0Y 1 H IGH526 Heavy Chain 9606
550 4N0Y 2 L IGH526 Light Chain 9606
551 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
552 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
553 5MTH 1 A, H antibody Fab heavy chain 10090
554 5MTH 2 B, L antibody Fab light chain 10090
555 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
556 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
557 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
558 1RZF 1 L Fab E51 light chain 9606
559 1RZF 2 H Fab E51 heavy chain 9606
560 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
561 4KTE 2 L GE148 Light Chain Fab 9544
562 5I8O 1 H HMM5 antibody heavy chain 9606
563 5I8O 2 L HMM5 antibody light chain 9606
564 4OUO 1 A anti Bla g 1 scFv 9031
565 4JG0 1 L Fab light chain 9606
566 4JG0 2 H Fab heavy chain 9606
567 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
568 4YGV 2 B, L aDabi-Fab2a light chain 9606
569 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
570 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
571 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
572 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
573 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
574 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
575 3EO0 1 A, C GC-1008 Fab Light Chain 10090
576 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
577 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
578 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
579 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
580 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
581 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
582 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
583 4POU 2 B VHH Antibody 9844
584 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
585 6J5D 2 H antibody heavy chain 10090
586 4FQI 3 H antibody CR9114 heavy chain Fab 9606
587 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
588 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
589 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
590 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
591 4JHA 2 L D25 light chain 9606
592 6B9Z 1 A Trastuzumab Fab light chain 10090
593 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
594 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
595 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
596 4PTT 1 A Antibody pn132p2C05, light chain 9606
597 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
598 6H70 2 C, D Nanobody (VHH) Nano-62 30538
599 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
600 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
601 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
602 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
603 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
604 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
605 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
606 2P42 2 B, D ANTIBODY CAB-RN05 9838
607 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
608 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
609 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
610 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
611 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
612 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
613 4DGV 1 H HCV1 Heavy Chain Fab 9606
614 4DGV 2 L HCV1 Light Chain 9606
615 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
616 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
617 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
618 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
619 5TH2 1 A, C cetuximab Fab, light chain 10090
620 5TH2 2 B, D cetuximab Fab, heavy chain 10090
621 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
622 5I8K 1 L HHH1 Fab Light chain 9606
623 5I8K 2 H HHH1 Fab Heavy chain 9606
624 4QLR 1 A, B Llama nanobody n02 VH domain 9844
625 5J56 2 B VHH single chain antibody V1C7 30538
626 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
627 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
628 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
629 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
630 1YNL 1 L Ig gamma light chain 10090
631 1YNL 2 H Ig gamma heavy chain 10090
632 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
633 5EPM 2 B, F Antibody Fab fragment light chain 10090
634 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
635 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
636 3UMT 1 A scFv heavy chain and light chain 10090
637 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
638 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
639 4NUJ 1 A PGT152 light chain 9606
640 4NUJ 2 B PGT152 heavy chain 9606
641 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
642 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
643 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
644 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
645 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
646 3U2S 2 B, L PG9 light chain 9606
647 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
648 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
649 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
650 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
651 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
652 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
653 4NUG 1 L PGT151 light chain 9606
654 4NUG 2 H PGT151 heavy chain 9606
655 3IU4 1 H chP3 Fab heavy chain 10090
656 3IU4 2 L chP3 Fab light chain 10090
657 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
658 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
659 6J5F 2 H antibody heavy chain 10090
660 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
661 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
662 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
663 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
664 1P7K 1 A, L antibody light chain FAB 10090
665 1P7K 2 B, H antibody heavy chain FAB 10090
666 4NBX 2 B A20.1 VHH 9844
667 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
668 3RVV 2 C 4C1 - light chain 10090
669 3RVV 3 D 4C1 - heavy chain 10090
670 4HEP 2 G vHH17 domain 9844
671 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
672 3P0Y 2 H Fab DL11 heavy chain 9606
673 3P0Y 3 L Fab DL11 light chain 9606
674 4NPY 1 A, L germline PGT121 light chain Fab 9606
675 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
676 6ANA 2 H LL2 Fab Heavy Chain 10090
677 6ANA 3 L LL2 Fab Light Chain 10090
678 5IBU 1 B, L 6652 Light Chain 9606
679 5IBU 2 G, H 6652 Heavy Chain 9606
680 5VPL 2 C 4C1 - LIGHT CHAIN 10090
681 5VPL 3 D 4C1 - HEAVY CHAIN 10090
682 6AOD 1 A FXIa Antibody FAB Light Chain 9606
683 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
684 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
685 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
686 2YPV 2 H FAB 12C1 10090
687 2YPV 3 L FAB 12C1 10090
688 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
689 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
690 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
691 4JY5 1 L PGT122 light chain Fab 9606
692 4JY5 2 H PGT122 heavy chain Fab 9606
693 6ELE 1 A, H fAB heavy chain 9606
694 6ELE 2 B, L fAB light chain 9606
695 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
696 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
697 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
698 6B5R 1 H CIS42 Fab Heavy chain 9606
699 6B5R 2 L CIS42 Fab Light chain 9606
700 5IML 2 B Nanobody 9835
701 3NAC 1 L Fab15 Mut7 light chain 9606
702 3NAC 2 H Fab15 Mut7 heavy chain 9606
703 3A6C 2 H IG VH, anti-lysozyme 10090
704 2DQD 2 H Ig VH,anti-lysozyme 10090
705 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
706 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
707 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
708 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
709 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
710 1Q72 1 L Fab M82G2, Light chain 10090
711 1Q72 2 H Fab M82G2, Heavy chain 10090
712 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
713 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
714 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
715 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
716 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
717 4YHO 1 H aDabi-Fab3 heavy chain 9606
718 4YHO 2 L aDabi-Fab3 light chain 9606
719 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
720 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
721 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
722 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
723 4DGY 1 H HCV1 Heavy Chain Fab 9606
724 4DGY 2 L HCV1 Light Chain 9606
725 3A67 2 H IG VH, anti-lysozyme 10090
726 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
727 5EN2 1 A GD01 heavy chain 10090
728 5EN2 2 B GD01 light chain 10090
729 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
730 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
731 1J1X 2 H Ig VH,anti-lysozyme 10090
732 5M2J 2 D Anti-(ED-B) scFV 9606
733 3MXW 2 L 5E1 light chain 9606
734 3MXW 3 H 5E1 heavy chain 9606
735 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
736 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
737 2DQC 2 H Ig VH,anti-lysozyme 10090
738 1J1O 2 H Ig VH,anti-lysozyme 10090
739 3EO9 1 L Efalizumab Fab fragment, light chain 9606
740 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
741 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
742 4M62 2 H, I GEP2 FV heavy chain 9606
743 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
744 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
745 5IVO 1 A BC2-nanobody 30538
746 1J1P 2 H Ig VH,anti-lysozyme 10090
747 6N35 1 K, L Fab 2G12 light chain 9606
748 6N35 2 H, M Fab 2G12 heavy chain 9606
749 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
750 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
751 4NBZ 2 B, D A26.8 VHH 9844
752 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
753 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
754 5WUV 1 L light chain 9606
755 5WUV 2 H heavy chain 9606
756 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
757 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
758 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
759 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
760 5AYU 2 H Ig VH,anti-lysozyme 10090
761 4JM4 1 H PGT 135 Heavy Chain Fab 9606
762 4JM4 2 L PGT 135 Light Chain Fab 9606
763 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
764 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
765 3A6B 2 H IG VH, anti-lysozyme 10090
766 2DQJ 2 H Ig VH,anti-lysozyme 10090
767 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
768 5YE4 2 B, D 1A9D7 L chain 10090
769 5F21 2 B nanobody MU375 9844
770 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
771 6B0G 1 C 1245 Antibody, Light Chain 9606
772 6B0G 2 D 1245 Antibody, Heavy Chain 9606
773 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
774 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
775 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
776 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
777 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
778 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
779 6D0X 1 A 2140 Antibody, heavy chain 9606
780 6D0X 2 B 1210 Antibody, light chain 9606
781 2P44 2 B ANTIBODY CAB-RN05 9838
782 6BE4 1 H Fab (F598) Heavy Chain 9606
783 6BE4 2 L Fab(F598) Light Chain 9606
784 5TPP 1 L DH270.5 Fab heavy chain 9606
785 5TPP 2 H DH270.5 Fab light chain 9606
786 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
787 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
788 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
789 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
790 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
791 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
792 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
793 5TP3 1 A, B F-VHH-4 9844
794 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
795 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
796 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
797 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
798 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
799 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
800 5TL5 1 L M2177 LIGHT CHAIN 10090
801 5TL5 2 H M2177 HEAVY CHAIN 10090
802 2FX7 1 L Fab 4E10 Light Chain 9606
803 2FX7 2 H Fab 4E10 Heavy Chain 9606
804 5Y9K 1 L belimumab light chain 9606
805 5Y9K 2 H belimumab heavy chain 9606
806 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
807 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
808 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
809 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
810 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
811 4LHJ 2 B Camelid antibody 30538
812 3WFH 1 A mAb Fab H fragment 10090
813 3WFH 2 B mAb Fab L fragment 10090
814 4BEL 2 D, E XA4813 9844
815 5M7Q 1 A, B Nanobody NbD2 9838
816 5H8D 1 A VHH nanobody 9844
817 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
818 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
819 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
820 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
821 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
822 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
823 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
824 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
825 3DUR 2 B, D Ig-like protein 10090
826 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
827 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
828 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
829 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
830 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
831 5HI4 3 D, L CAT-2000 FAB light chain 9606
832 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
833 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
834 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
835 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
836 3RVW 2 C 4C1 - light chain 10090
837 3RVW 3 D 4C1 - heavy chain 10090
838 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
839 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
840 5XKU 2 B HNIgGA6 light chain 9606
841 5XKU 3 C HNIgGA6 heavy chain 9606
842 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
843 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
844 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
845 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
846 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
847 5HI5 3 D, L CAT-2000 light chain 9606
848 5JO5 1 A, C, E, H 10E8 gHV 9606
849 5JO5 2 B, D, F, L 10E8 gLV 9606
850 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
851 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
852 2XV6 2 B, D CAMELID VHH 9 30538
853 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
854 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
855 5CCK 2 L Antibody 3BC315 Fab light chain 9606
856 5VM0 1 A, B Camelid Nanobody VHH T9 9844
857 5I76 1 A, C FM318_light_chain 1383439
858 5I76 2 B, D FM318_heavy_cahin 1383439
859 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
860 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
861 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
862 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
863 5I18 1 L FAB LIGHT CHAIN 9606
864 5I18 2 H FAB HEAVY CHAIN 9606
865 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
866 4JN1 2 L anti-dabigatran Fab1, light chain 10090
867 4ZG1 1 A, B, C, D, E, F NB17 9844
868 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
869 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
870 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
871 4G5Z 2 L canakinumab antibody fragment light chain 9606
872 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
873 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
874 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
875 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
876 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
877 2OK0 2 L Fab ED10 light chain 10090
878 2OK0 3 H Fab ED10 heavy chain 10090
879 6BAN 2 B, D, F, H Variable domain R11 Heavy chain 9606
880 3SOB 1 L antibody light chain 9606
881 3SOB 3 H antibody heavy chain 9606
882 6B5M 1 H CIS43 Fab Heavy chain 9606
883 6B5M 2 L CIS43 Fab Light chain 9606
884 4I1N 2 B Protein ca1697 (nanobody) 9844
885 5AWN 1 H Heavy chain of 3BC176 Fab 9606
886 5AWN 2 L Light chain of 3BC176 Fab 9606
887 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
888 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
889 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
890 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
891 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
892 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
893 5DR5 2 L AbD09097 Fab light chain 9606
894 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
895 2IH3 1 A FAB Heavy Chain 10090
896 2IH3 2 B FAB Light Chain 10090
897 4KQ3 1 L CNTO3186 light chain Fab 9606
898 4KQ3 2 H CNTO3186 heavy chain Fab 9606
899 6F0D 1 A, B VHH antibody BCD090-M2 9844
900 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
901 6AQ7 3 L POM6 FAB light CHAIN 10090
902 4JFX 1 A, L Fab light chain 9606
903 4JFX 2 B, H Fab heavy chain 9606
904 3SGE 1 I, L Light Chain 10090
905 3SGE 2 H, J Heavy Chain 10090
906 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
907 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
908 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
909 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
910 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
911 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
912 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
913 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
914 5FHB 1 H Antibody 100 Fab heavy chain 9606
915 5FHB 2 L Antibody 100 Fab light chain 9606
916 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
917 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
918 1JGU 1 L Antibody Light Chain 10090
919 1JGU 2 H Antibody Heavy Chain 10090
920 4I77 1 H Lebrikizumab heavy chain Fab 9606
921 4I77 2 L Lebrikizumab light chain Fab 9606
922 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
923 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
924 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
925 4O4Y 2 H 2095-2 heavy chain 9986
926 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
927 5OBF 1 H fAb Heavy chain 10090